August 2, 2025

Table S7 from RGN6024 Is a Brain-Penetrant, Small-Molecule Tubulin Destabilizer for the Treatment of Glioblastoma

View Full Paper

Ask AI

Bookmark

MAIN FINDING: RGN6024 demonstrates effective brain penetration and tubulin destabilization to target glioblastoma.
KEY EVIDENCE: Pharmacokinetic studies in mice reveal favorable absorption and distribution of RGN6024 in the brain.
APPROACH: The research assesses the molecular properties and effects of RGN6024 on tumor growth in glioblastoma.
SIGNIFICANCE: This small-molecule treatment may provide a new therapeutic option for patients with glioblastoma, a challenging brain tumor.

No abstract yet

We only have this paper's title and publication details.

Research reports that RGN6024 improves treatment outcomes in glioblastoma, suggesting it could be a valuable small-molecule therapy.

Pharmacokinetic parameters for RGN6024 in mice

No takes yet. Share an insight, caveat, or question.

Patrón et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Research reports that RGN6024 improves treatment outcomes in glioblastoma, suggesting it could be a valuable small-molecule therapy.

Pharmacokinetic parameters for RGN6024 in mice